Gleneagles Hospital Mumbai Launches Institute of Onco-Science for Comprehensive Cancer Care

Mumbai: As India faces an alarming surge in cancer incidence, Gleneagles Hospital, Parel, Mumbai, has unveiled the Institute of Onco-Science, a comprehensive and fully coordinated cancer care centre designed to offer patients faster diagnosis, multi-specialty expertise, and advanced treatment under one integrated roof.

Cancer is rapidly becoming one of India’s biggest health challenges. According to a recent study by the Indian Council of Medical Research (ICMR) published in the Journal of the American Medical Association (JAMA), India is expected to record 1.56 million new cancer cases and 874,404 deaths in 2024. Breast, GI and HPB, head & neck, and uro-oncological cancers are among the fastest-rising—largely due to stress, lifestyle changes, environmental exposure, and low screening rates.

Bringing India’s Leading Cancer Specialists Together

Addressing this urgent need for structured and timely care, Gleneagles Hospital has assembled four of the country’s most respected oncological experts within one coordinated facility:

• Prof. Shailesh V. Shrikhande – GI and HPB cancer
• Dr Prathamesh Pai – Head & Neck Cancer
• Dr Pradeep Rao – Uro-Cancer
• Dr Tushar Jadhav – Breast Cancer

This distinguished team represents decades of high-volume clinical expertise, research excellence, and leadership in organ-specific cancers.

The Institute of Onco-Science eliminates the traditional fragmentation of cancer care. Instead of traveling between multiple hospitals or departments, patients now receive:

• Single-window access to all major cancer specialists
• Accelerated diagnosis through coordinated evaluations
• Unified treatment planning, ensuring clarity and confidence for families
• Cutting-edge therapies powered by precision oncology
• Holistic support services, including counselling, nutrition, and survivorship care

This multidisciplinary approach not only enhances clinical outcomes but also reduces emotional and financial strain on patients and caregivers.

Gleneagles’ new institute places strong emphasis on:

• Early detection and targeted screening for high-risk populations
• Advanced minimally invasive treatments for better recovery
• Evidence-based, personalised treatment pathways
• Continuous follow-up and long-term survivorship care

By combining innovation, empathy, and expert-led interventions, the centre aims to redefine cancer care standards in Mumbai and beyond.

Dr Bipin Chevale, CEO, Gleneagles Hospital Mumbai, said, “We are proud to introduce the Institute of Onco-Science at a time when cancer is impacting countless families across India. Cancer is not just a medical condition — it disrupts hope, stability, and the future of an entire household. By bringing leading specialists together under one roof, we aim to provide every patient with timely, coordinated, and compassionate care.”

“Our mission at Gleneagles is to strengthen early detection and ensure every patient receives a fair chance at recovery. This institute is a significant step toward building a future where expert cancer care is accessible, organized, and delivered with empathy.”